DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ajanta Pharma
Ajanta Pharma
SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI Trading As ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP
Ajanta Pharma Limited
Inner 25 India Pharma & Healthcare Fund
MF 35 Fund One Pager
CARE Ratings Ltd
PUBLIC ANNOUNCEMENT for the ATTENTION of EQUITY SHAREHOLDERS/ BENEFICIAL OWNERS of As Partner of Ganga Exports, Where the Partner’S Share Being 37.5%
Defying Challenges Achieving Growth
List of Nodal Officer
Systematix Institutional Equities
Media Release
Draft Letter of Offer This Document Is Important and Requires Your Immediate Attention
Placement Report 2015-16.Pdf
Booked Profit/Loss Table Name of the Stock Sector Reco Date Wgt% No
1445062001 Pectylin-C Expectorant Ipca Laboratories Ltd. India Freely 1446062001T Metrogyl V-Gel with Unique Pharmaceutical India Third Schedule Applicator Labs
BSE Code NSE Code ISIN Scrip Name NSE Intraday Margin % BSE
Ajanta Pharmaceuticals (AJAPHA)
India Disclosure Index 2016
(Single Scrip Lending) List of Approved Securities
Top View
Ajanta Pharmaceuticalsfebruary 06, 2020
Clinica Baviera Milan Testimonials
7.2.2 Any Other Relevent Information
American Century Investments® Quarterly Portfolio Holdings Avantis
Front Page.CDR
Inner 25 India Pharma & Healthcare Fund
Registered Firm's in WCR Update up to Febuary-2013 Sr
Inner 10 Large & Mid Cap Fund
Ajanta Pharmaceuticals (AJAPHA) | 1543
List of Registered Firms Over WCR As Per New Policy of Rly. Board up to 23.3.12
First Light 31Jul20-Research
IPCA Laboratories Ltd
Plan. Prepare. Perform
LIST of DOMESTIC CLIENTS Ajanta Pharma Ltd
Market Masala… the Flavors That Influenced the Market This Week
FTSE Publications
The Small Big Dream
PPA Code Company Name PINFO INFOSYS TECHNOLOGIES
Annual Report the Compass for Our Journey
Loan Against Securities – Multiple Scrip
List of Top 100 Pharma Companies by Turnover
List of Taxpayers Allotted to Center Having Turnover of More Than Or Equal to 1.5 Crore
Letter of Offer This Document Is Important and Requires Your Immediate Attention
India Disclosure Index
Inner 10 Large & Mid Cap Fund
AJANTA PHARMA LIMITED Post Buyback PA 20 March 2019.Pmd
Sheet1 Page 1 PLACE Ajanta Pharma Limited Mumbai Ajanta Pharma
Looking Beyond Challenges Embracing Tomorrow
Approved Scrips Aug-2021
Loan Against Securities – Approved Multiple Scrips
Ajanta Pharma Companyname
Extract of Holding Statement of Stakeholders Empowerment
Scrip List Page 1
Retirement Strategy Fund 2050 Description Plan 3S DCP & JRA ACTIVIA PROPERTIES INC REIT 0.0134% 0.0134% AEON REIT INVESTMENT
Buyback Offer 2020 : Ajanta Pharma Limited
MF 35 Fund One Pager
Alphabetical Index 1000
MF One Pager